×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BNGO – bionano genomics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BNGO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/3
08:23 am
bngo
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies [Yahoo! Finance]
Medium
Report
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies [Yahoo! Finance]
12/3
08:00 am
bngo
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
Low
Report
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
11/24
07:19 am
bngo
Bionano Genomics (NASDAQ:BNGO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Bionano Genomics (NASDAQ:BNGO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/14
01:11 pm
bngo
Bionano Genomics (NASDAQ:BNGO) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Bionano Genomics (NASDAQ:BNGO) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
11/12
08:37 am
bngo
Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2025 Result [Yahoo! Finance]
Low
Report
Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2025 Result [Yahoo! Finance]
11/6
08:00 am
bngo
Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia
Medium
Report
Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia
10/30
04:05 pm
bngo
Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025
Low
Report
Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025
10/23
08:00 am
bngo
Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) Meeting
Low
Report
Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) Meeting
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:13 pm
bngo
Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: Lind Global Fund III LP
Medium
Report
Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: Lind Global Fund III LP
11/14
03:10 pm
bngo
Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: Iroquois Capital Management, LLC
Medium
Report
Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: Iroquois Capital Management, LLC
11/14
02:45 pm
bngo
Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: Iroquois Capital Management, LLC
Medium
Report
Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: Iroquois Capital Management, LLC
10/17
04:32 pm
bngo
Form 424B5 Bionano Genomics, Inc.
Medium
Report
Form 424B5 Bionano Genomics, Inc.
9/24
08:00 pm
bngo
Form SCHEDULE 13G Bionano Genomics, Inc. Filed by: Lind Global Fund III LP
Medium
Report
Form SCHEDULE 13G Bionano Genomics, Inc. Filed by: Lind Global Fund III LP
9/22
10:01 am
bngo
Form SCHEDULE 13G Bionano Genomics, Inc. Filed by: CVI Investments, Inc.
Low
Report
Form SCHEDULE 13G Bionano Genomics, Inc. Filed by: CVI Investments, Inc.
9/19
04:34 pm
bngo
Form SCHEDULE 13G Bionano Genomics, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
Low
Report
Form SCHEDULE 13G Bionano Genomics, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
9/18
08:13 am
bngo
Form SCHEDULE 13G Bionano Genomics, Inc. Filed by: Iroquois Capital Management, LLC
Low
Report
Form SCHEDULE 13G Bionano Genomics, Inc. Filed by: Iroquois Capital Management, LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
10/16
Top Researchers to Present Discoveries Made Possible by Bionano’s Saphyr System for Genome Imaging Technology at the ASHG 2019 Annual Meeting
417.6%
2/28 Bionano Genomics to Report Fourth Quarter and Year End 2019 Financial Results and Host a Conference Call and Webcast on March 5 25.0%
11/12 Takeaways from AMP 2019 in Baltimore: Users of Bionano’s Saphyr System Presented Results from Multiple Studies Demonstrating the System’s Utility for a Variety of Disease Indications 24.7%
10/21 Form S-1MEF Bionano Genomics, Inc 20.0%
11/6 Novogene Adopts Bionano’s Saphyr System Adding Saphyr’s Ultra-Sensitive and Ultra-Specific Structural Variation Detection to their Repertoire of Services 14.6%
4/24 BioNano Genomics Inc (NASDAQ: BNGO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 12.7%
6/13 Leading Scientists and Clinicians Are Presenting Results From a Record Number of Studies at ESHG 2019 Showing How the Saphyr System From Bionano Genomics Provides Critical Insights Into Cancer and Genetic Disease and is Leading the Way to Digital Cytogene 9.1%
10/22 Form EFFECT Bionano Genomics, Inc 7.4%
3/6 Form 4 Bionano Genomics, Inc For: Mar 01 Filed by: Robinson Warren 7.0%
2/20 Form 4 Bionano Genomics, Inc For: Feb 18 Filed by: Adams Heather 6.7%
2/28 Bionano Genomics to Report Fourth Quarter and Year End 2019 Financial Results and Host a Conference Call and Webcast on March 5 25.0%
11/12 Takeaways from AMP 2019 in Baltimore: Users of Bionano’s Saphyr System Presented Results from Multiple Studies Demonstrating the System’s Utility for a Variety of Disease Indications 24.7%
10/21 Form S-1MEF Bionano Genomics, Inc 20.0%
11/6 Novogene Adopts Bionano’s Saphyr System Adding Saphyr’s Ultra-Sensitive and Ultra-Specific Structural Variation Detection to their Repertoire of Services 14.6%
4/24 BioNano Genomics Inc (NASDAQ: BNGO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 12.7%
6/13 Leading Scientists and Clinicians Are Presenting Results From a Record Number of Studies at ESHG 2019 Showing How the Saphyr System From Bionano Genomics Provides Critical Insights Into Cancer and Genetic Disease and is Leading the Way to Digital Cytogene 9.1%
10/22 Form EFFECT Bionano Genomics, Inc 7.4%
3/6 Form 4 Bionano Genomics, Inc For: Mar 01 Filed by: Robinson Warren 7.0%
2/20 Form 4 Bionano Genomics, Inc For: Feb 18 Filed by: Adams Heather 6.7%
TOP News Decliners
10/18
Form SC 13G/A Bionano Genomics, Inc Filed by: HIRSCHMAN ORIN
-49.5%
4/1 Form S-1MEF Bionano Genomics, Inc -37.4%
3/5 Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update -32.9%
3/10 Bionano Genomics Will Be Used in Research Identifying Gene Variants that Contribute to Coronavirus Disease Susceptibility -30.9%
10/17 Bionano Genomics down 23% on equity offering [Seeking Alpha] -30.7%
3/31 Bionano Genomics to Support Largest Study to Date on COVID-19 Disease Susceptibility -29.3%
3/10 Form 10-K Bionano Genomics, Inc For: Dec 31 -27.0%
9/18 Form S-1 Bionano Genomics, Inc -20.1%
10/23 Form 424B4 Bionano Genomics, Inc -14.1%
11/7 Form 8-K Bionano Genomics, Inc For: Nov 07 -13.7%
4/1 Form S-1MEF Bionano Genomics, Inc -37.4%
3/5 Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update -32.9%
3/10 Bionano Genomics Will Be Used in Research Identifying Gene Variants that Contribute to Coronavirus Disease Susceptibility -30.9%
10/17 Bionano Genomics down 23% on equity offering [Seeking Alpha] -30.7%
3/31 Bionano Genomics to Support Largest Study to Date on COVID-19 Disease Susceptibility -29.3%
3/10 Form 10-K Bionano Genomics, Inc For: Dec 31 -27.0%
9/18 Form S-1 Bionano Genomics, Inc -20.1%
10/23 Form 424B4 Bionano Genomics, Inc -14.1%
11/7 Form 8-K Bionano Genomics, Inc For: Nov 07 -13.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: